Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.

Davis KL, Mohs RC.

Am J Psychiatry. 1982 Nov;139(11):1421-4.

PMID:
6753611
[PubMed - indexed for MEDLINE]
2.

Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease.

Thal LJ, Masur DM, Blau AD, Fuld PA, Klauber MR.

J Am Geriatr Soc. 1989 Jan;37(1):42-8. Review.

PMID:
2642499
[PubMed - indexed for MEDLINE]
3.

Alternatives in the treatment of memory loss in patients with Alzheimer's disease.

Volger BW.

Clin Pharm. 1991 Jun;10(6):447-56. Review.

PMID:
2065522
[PubMed - indexed for MEDLINE]
4.

Measurement of cholinergic drug effects on memory in Alzheimer's disease.

Brinkman SD, Gershon S.

Neurobiol Aging. 1983 Summer;4(2):139-45. Review.

PMID:
6355883
[PubMed - indexed for MEDLINE]
5.

Potential pharmacotherapy of Alzheimer disease. A comparison of various forms of physostigmine administration.

Becker R, Giacobini E, Elble R, McIlhany M, Sherman K.

Acta Neurol Scand Suppl. 1988;116:19-32. Review.

PMID:
3043998
[PubMed - indexed for MEDLINE]
6.

Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies.

Braida D, Sala M.

CNS Drug Rev. 2001 Winter;7(4):369-86. Review.

PMID:
11830755
[PubMed - indexed for MEDLINE]
7.

[Semantic memory in Alzheimer's disease: contributions of semantic priming].

Laisney M, Giffard B, Eustache F.

Psychol Neuropsychiatr Vieil. 2004 Jun;2(2):107-15. Review. French.

PMID:
15683973
[PubMed - indexed for MEDLINE]
8.

"Brain-specific" nutrients: a memory cure?

McDaniel MA, Maier SF, Einstein GO.

Nutrition. 2003 Nov-Dec;19(11-12):957-75. Review.

PMID:
14624946
[PubMed - indexed for MEDLINE]
9.

[Tacrine].

Dávila C, Viteri C, de Castro P.

Rev Med Univ Navarra. 1997 Jan-Mar;41(1):58-64. Review. Spanish.

PMID:
9527715
[PubMed - indexed for MEDLINE]
10.

Semantic memory disorders in Alzheimer's disease: clues from semantic priming effects.

Giffard B, Desgranges B, Eustache F.

Curr Alzheimer Res. 2005 Oct;2(4):425-34. Review.

PMID:
16248848
[PubMed - indexed for MEDLINE]
11.

Long-term cholinesterase inhibitor treatment of Alzheimer's disease.

Johannsen P.

CNS Drugs. 2004;18(12):757-68. Review.

PMID:
15377166
[PubMed - indexed for MEDLINE]
12.

Evaluation of drugs in Alzheimer's disease and age-associated memory impairment.

Crook TH, Johnson BA, Larrabee GJ.

Psychopharmacol Ser. 1990;8:37-55. Review. No abstract available.

PMID:
2198563
[PubMed - indexed for MEDLINE]
13.

Cholinergic approaches to the treatment of Alzheimer's disease.

Hollander E, Mohs RC, Davis KL.

Br Med Bull. 1986 Jan;42(1):97-100. Review. No abstract available.

PMID:
3006861
[PubMed - indexed for MEDLINE]
14.

Memory training and memory improvement in Alzheimer's disease: rules and exceptions.

Bäckman L.

Acta Neurol Scand Suppl. 1992;139:84-9. Review. No abstract available.

PMID:
1414274
[PubMed - indexed for MEDLINE]
15.

The memory deficits in Alzheimer-type dementia: a review.

Morris RG, Kopelman MD.

Q J Exp Psychol A. 1986 Nov;38(4):575-602. Review. No abstract available.

PMID:
3544082
[PubMed - indexed for MEDLINE]
16.

Evolving concepts of memory.

Cameron DE.

Recent Adv Biol Psychiatry. 1966;9:1-20. Review. No abstract available.

PMID:
4878857
[PubMed - indexed for MEDLINE]
17.

[The role of the endocrine system in memory disorders].

Bidzan L.

Psychiatr Pol. 1988 Sep-Oct;22(5):363-8. Review. Polish. No abstract available.

PMID:
2907660
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk